The impact of the Covid-19 pandemic on R&D and commercialization of new drugs and vaccines
Intoccia, Andrea Erminio (A.A. 2019/2020) The impact of the Covid-19 pandemic on R&D and commercialization of new drugs and vaccines. Tesi di Laurea in Health care management, Luiss Guido Carli, relatore Daniele Mascia, pp. 150. [Master's Degree Thesis]
PDF (Full text)
Restricted to Registered users only Download (3MB) | Request a copy |
Abstract/Index
From laboratory to patient: the journey of medicinal products. Product roadmap of medicines. Vaccine making: a complex pipeline. Making steps toward the future: how to cut decades of research and technology implementation thanks to new opportunities and challenges. Procedures questioned by the global health emergency due to the pandemic crisis: new models with high risks management are born. Impacts of Covid-19 on the pharmaceutical sector. Biopharmaceutical companies: the fight against the novel Coronavirus. Partnership and collaboration in response to Covid-19 pandemic. New strategies for biopharma: the next normal. Lesson learned from Covid-19 pandemic for a future based on innovation. Shaping the next normal.
References
Bibliografia: pp. 122-149.
Thesis Type: | Master's Degree Thesis |
---|---|
Institution: | Luiss Guido Carli |
Degree Program: | Master's Degree Programs > Master's Degree Program in Gestione d'impresa (LM-77) |
Chair: | Health care management |
Thesis Supervisor: | Mascia, Daniele |
Thesis Co-Supervisor: | Homberg, Fabian Kurt Falk |
Academic Year: | 2019/2020 |
Session: | Extraordinary |
Additional Information: | Sessione anticipata 2020/2021. |
Deposited by: | Alessandro Perfetti |
Date Deposited: | 14 Jun 2021 07:03 |
Last Modified: | 14 Jun 2021 07:03 |
URI: | https://tesi.luiss.it/id/eprint/29747 |
Downloads
Downloads per month over past year
Repository Staff Only
View Item |